CHEK2 and breast cancer: The risk associated with breast cancer for P/LP variants in PALB2 varied between moderate and high (OR 3.83–5.02), whereas those in CHEK2 and ATM were associated with moderate risk (OR 2.54–2.47 and OR 1.82–2.10, respectively) [7,11].